TY - STD TI - Copeland G LA, Firth R, et al. Cancer in North America: 2008–2012. North American Association of Central Cancer Registries, Inc, Springfield, IL. June 2015.;Volume One: Combined Cancer Incidence for the United States, Canada and North America. ID - ref1 ER - TY - JOUR AU - Lund, M. J. AU - Trivers, K. F. AU - Porter, P. L. PY - 2009 DA - 2009// TI - Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA JO - Breast Cancer Res Treat VL - 113 UR - https://doi.org/10.1007/s10549-008-9926-3 DO - 10.1007/s10549-008-9926-3 ID - Lund2009 ER - TY - JOUR AU - Loo, L. W. AU - Wang, Y. AU - Flynn, E. M. PY - 2011 DA - 2011// TI - Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women JO - Breast Cancer Res Treat VL - 127 UR - https://doi.org/10.1007/s10549-010-1297-x DO - 10.1007/s10549-010-1297-x ID - Loo2011 ER - TY - JOUR AU - Danforth, D. N. PY - 2013 DA - 2013// TI - Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors JO - Breast Cancer Res VL - 15 UR - https://doi.org/10.1186/bcr3429 DO - 10.1186/bcr3429 ID - Danforth2013 ER - TY - JOUR AU - Parker, J. S. AU - Mullins, M. AU - Cheang, M. C. PY - 2009 DA - 2009// TI - Supervised risk predictor of breast cancer based on intrinsic subtypes JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1370 DO - 10.1200/JCO.2008.18.1370 ID - Parker2009 ER - TY - JOUR AU - Sorlie, T. AU - Tibshirani, R. AU - Parker, J. PY - 2003 DA - 2003// TI - Repeated observation of breast tumor subtypes in independent gene expression data sets JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.0932692100 DO - 10.1073/pnas.0932692100 ID - Sorlie2003 ER - TY - JOUR AU - Perou, C. M. PY - 2011 DA - 2011// TI - Molecular stratification of triple-negative breast cancers JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2011-S1-61 DO - 10.1634/theoncologist.2011-S1-61 ID - Perou2011 ER - TY - JOUR AU - Dang, C. V. M. Y. C. PY - 2012 DA - 2012// TI - On the path to cancer JO - Cell VL - 149 UR - https://doi.org/10.1016/j.cell.2012.03.003 DO - 10.1016/j.cell.2012.03.003 ID - Dang2012 ER - TY - JOUR AU - Liao, D. J. AU - Dickson, R. B. PY - 2000 DA - 2000// TI - C-Myc in breast cancer JO - Endocr Relat Cancer VL - 7 UR - https://doi.org/10.1677/erc.0.0070143 DO - 10.1677/erc.0.0070143 ID - Liao2000 ER - TY - JOUR AU - Deming, S. L. AU - Nass, S. J. AU - Dickson, R. B. PY - 2000 DA - 2000// TI - C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance JO - Br J Cancer VL - 83 UR - https://doi.org/10.1054/bjoc.2000.1522 DO - 10.1054/bjoc.2000.1522 ID - Deming2000 ER - TY - JOUR AU - Chrzan, P. AU - Skokowski, J. AU - Karmolinski, A. PY - 2001 DA - 2001// TI - Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue JO - Clin Biochem VL - 34 UR - https://doi.org/10.1016/S0009-9120(01)00260-0 DO - 10.1016/S0009-9120(01)00260-0 ID - Chrzan2001 ER - TY - JOUR AU - Blancato, J. AU - Singh, B. AU - Liu, A. PY - 2004 DA - 2004// TI - Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601703 DO - 10.1038/sj.bjc.6601703 ID - Blancato2004 ER - TY - JOUR AU - Bouchalova, K. AU - Cizkova, M. AU - Cwiertka, K. PY - 2009 DA - 2009// TI - Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment JO - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub VL - 153 UR - https://doi.org/10.5507/bp.2009.002 DO - 10.5507/bp.2009.002 ID - Bouchalova2009 ER - TY - JOUR AU - Hynes, N. E. AU - Myc, L. H. A. PY - 2001 DA - 2001// TI - Mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase JO - J Mammary Gland Biol Neoplasia VL - 6 UR - https://doi.org/10.1023/A:1009528918064 DO - 10.1023/A:1009528918064 ID - Hynes2001 ER - TY - JOUR AU - Todorovic-Rakovic, N. AU - Neskovic-Konstantinovic, Z. AU - Nikolic-Vukosavljevic, D. PY - 2012 DA - 2012// TI - C-myc as a predictive marker for chemotherapy in metastatic breast cancer JO - Clin Exp Med VL - 12 UR - https://doi.org/10.1007/s10238-011-0169-y DO - 10.1007/s10238-011-0169-y ID - Todorovic-Rakovic2012 ER - TY - JOUR AU - Park, K. AU - Kwak, K. AU - Kim, J. PY - 2005 DA - 2005// TI - C-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers JO - Hum Pathol VL - 36 UR - https://doi.org/10.1016/j.humpath.2005.04.016 DO - 10.1016/j.humpath.2005.04.016 ID - Park2005 ER - TY - JOUR AU - Nair, R. AU - Roden, D. L. AU - Teo, W. S. PY - 2014 DA - 2014// TI - C-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.368 DO - 10.1038/onc.2013.368 ID - Nair2014 ER - TY - JOUR AU - Blancato, J. K. AU - Williams, M. S. AU - Dickson, R. B. PY - 2006 DA - 2006// TI - Fluorescence in situ hybridization assessment of c-myc gene amplification in breast tumor tissues JO - Methods Mol Med VL - 120 ID - Blancato2006 ER - TY - JOUR AU - Li, C. AU - Bai, J. AU - Hao, X. PY - 2014 DA - 2014// TI - Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients JO - Cell Cycle VL - 13 UR - https://doi.org/10.4161/cc.28201 DO - 10.4161/cc.28201 ID - Li2014 ER - TY - JOUR AU - Yasojima, H. AU - Shimomura, A. AU - Naoi, Y. PY - 2011 DA - 2011// TI - Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer JO - Eur J Cancer VL - 47 UR - https://doi.org/10.1016/j.ejca.2011.06.017 DO - 10.1016/j.ejca.2011.06.017 ID - Yasojima2011 ER - TY - JOUR AU - Horiuchi, D. AU - Kusdra, L. AU - Huskey, N. E. PY - 2012 DA - 2012// TI - MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition JO - J Exp Med VL - 209 UR - https://doi.org/10.1084/jem.20111512 DO - 10.1084/jem.20111512 ID - Horiuchi2012 ER - TY - JOUR AU - Singhi, A. D. AU - Cimino-Mathews, A. AU - Jenkins, R. B. PY - 2012 DA - 2012// TI - MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors JO - Mod Pathol VL - 25 UR - https://doi.org/10.1038/modpathol.2011.171 DO - 10.1038/modpathol.2011.171 ID - Singhi2012 ER - TY - JOUR AU - Alles, M. C. AU - Gardiner-Garden, M. AU - Nott, D. J. PY - 2009 DA - 2009// TI - Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0004710 DO - 10.1371/journal.pone.0004710 ID - Alles2009 ER - TY - JOUR AU - Perez, E. A. AU - Jenkins, R. B. AU - Dueck, A. C. PY - 2011 DA - 2011// TI - C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.30.2125 DO - 10.1200/JCO.2010.30.2125 ID - Perez2011 ER - TY - JOUR AU - Wong, M. S. AU - Murphy, L. C. PY - 1991 DA - 1991// TI - Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells JO - J Steroid Biochem Mol Biol VL - 39 UR - https://doi.org/10.1016/0960-0760(91)90010-3 DO - 10.1016/0960-0760(91)90010-3 ID - Wong1991 ER - TY - JOUR AU - Wang, C. AU - Mayer, J. A. AU - Mazumdar, A. PY - 2011 DA - 2011// TI - Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor JO - Mol Endocrinol VL - 25 UR - https://doi.org/10.1210/me.2011-1037 DO - 10.1210/me.2011-1037 ID - Wang2011 ER -